• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Priority-setting, the Indian way.

作者信息

Rao Neethi V, Downey Laura, Jain Nishant, Baru Rama, Cluzeau Francoise

机构信息

Imperial College, London, UK.

International Decision Support Initiative, London, UK.

出版信息

J Glob Health. 2018 Dec;8(2):020311. doi: 10.7189/jogh.08.020311.

DOI:10.7189/jogh.08.020311
PMID:30479747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237104/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae4/6237104/932bd8749d22/jogh-08-020311-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae4/6237104/a8891ce9566a/jogh-08-020311-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae4/6237104/932bd8749d22/jogh-08-020311-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae4/6237104/a8891ce9566a/jogh-08-020311-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae4/6237104/932bd8749d22/jogh-08-020311-Fa.jpg

相似文献

1
Priority-setting, the Indian way.确定优先事项的印度方式。
J Glob Health. 2018 Dec;8(2):020311. doi: 10.7189/jogh.08.020311.
2
Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia.将证据转化为优先事项，实现全民健康覆盖：来自印度尼西亚的经验。
Inquiry. 2020 Jan-Dec;57:46958020924920. doi: 10.1177/0046958020924920.
3
Priority setting for new technologies in medicine: qualitative case study.医学新技术的优先级设定：定性案例研究
BMJ. 2000 Nov 25;321(7272):1316-8. doi: 10.1136/bmj.321.7272.1316.
4
Health services research in Europe: evaluating and improving its contribution to health care policy.欧洲的卫生服务研究：评估并提升其对卫生保健政策的贡献。
J Health Serv Res Policy. 2011 Jul;16 Suppl 2:1-5. doi: 10.1258/jhsrp.2011.011058.
5
Priority setting in health care: unburdening from the burden of disease.医疗保健中的优先事项设定：减轻疾病负担
Aust N Z J Public Health. 1997 Dec;21(7):680-1. doi: 10.1111/j.1467-842x.1997.tb01779.x.
6
Organizational Formation for Priority Setting: Historical Perspectives and Thematic Analysis of India's Health Technology Assessment Agency.组织形成优先事项设定：印度卫生技术评估机构的历史透视和主题分析。
Health Syst Reform. 2023 Dec 31;9(3):2327414. doi: 10.1080/23288604.2024.2327414. Epub 2024 May 7.
7
Priority setting for health technology assessment in The Netherlands: principles and practice.
Health Policy. 2002 Dec;62(3):227-42. doi: 10.1016/s0168-8510(02)00037-4.
8
Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India.为十亿人口做预算：在印度实现全民健康覆盖应用卫生技术评估（HTA）。
Health Res Policy Syst. 2018 Nov 29;16(1):115. doi: 10.1186/s12961-018-0378-x.
9
Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.澳大利亚的社会价值观与卫生优先事项设定：一项应用于卫生技术评估背景的分析
Health Policy. 2015 Feb;119(2):127-36. doi: 10.1016/j.healthpol.2014.09.003. Epub 2014 Sep 16.
10
Priority setting in health policy in Sweden and a comparison with Norway.瑞典卫生政策中的优先事项设定以及与挪威的比较。
Health Policy. 1999 Dec;50(1-2):1-22. doi: 10.1016/s0168-8510(99)00061-5.

引用本文的文献

1
Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India.综合效用成本比排行榜：印度卫生政策决策成本效益证据的系统评价。
Front Public Health. 2022 Oct 13;10:831254. doi: 10.3389/fpubh.2022.831254. eCollection 2022.
2
Exploring the possible sources of fiscal space for health in India: insights from political regimes.探讨印度卫生领域财政空间的可能来源：政治体制的启示。
Health Res Policy Syst. 2022 Mar 24;20(1):32. doi: 10.1186/s12961-022-00831-4.
3
Impact of public-funded health insurances in India on health care utilisation and financial risk protection: a systematic review.

本文引用的文献

1
Defining a Health Benefits Package: What Are the Necessary Processes?定义健康福利套餐：必要流程有哪些？
Health Syst Reform. 2016 Jan 2;2(1):39-50. doi: 10.1080/23288604.2016.1124171.
2
Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India.将卫生技术评估制度化：在印度设立医疗技术评估委员会。
BMJ Glob Health. 2017 Jun 26;2(2):e000259. doi: 10.1136/bmjgh-2016-000259. eCollection 2017.
3
Mitigating regulatory impact: the case of partial price controls on metformin in India.
印度公共资助的医疗保险对医疗保健利用和财务风险保护的影响：系统评价。
BMJ Open. 2021 Dec 22;11(12):e050077. doi: 10.1136/bmjopen-2021-050077.
4
Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience.建设印度卫生系统循证优先事项设定的能力：一次国际合作经验
Health Policy Open. 2020 Dec;1:100004. doi: 10.1016/j.hpopen.2020.100004.
减轻监管影响：印度二甲双胍部分价格管制的案例
Health Policy Plan. 2017 Mar 1;32(2):194-204. doi: 10.1093/heapol/czw109.
4
Using health technology assessment for informing coverage decisions in Thailand.利用健康技术评估为泰国的覆盖决策提供信息。
J Comp Eff Res. 2012 Mar;1(2):137-46. doi: 10.2217/cer.12.10.
5
Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund.健康技术评估作为提高资金价值的机制：向全球基金提出的建议。
Global Health. 2013 Aug 21;9:35. doi: 10.1186/1744-8603-9-35.
6
Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?卫生技术评估在政策制定中的传播和应用：对分散的医疗保健系统有哪些借鉴意义？
Health Policy. 2012 Dec;108(2-3):194-202. doi: 10.1016/j.healthpol.2012.09.017. Epub 2012 Oct 23.
7
Health technology assessment in Canada: 20 years strong?加拿大的卫生技术评估：20 年成效显著？
Value Health. 2009 Jun;12 Suppl 2:S14-9. doi: 10.1111/j.1524-4733.2009.00554.x.
8
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.36个发展中国家和中等收入国家的药品价格、可及性及可负担性：一项二次分析
Lancet. 2009 Jan 17;373(9659):240-9. doi: 10.1016/S0140-6736(08)61762-6. Epub 2008 Nov 29.
9
Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.提高研究证据在指南制定中的应用：11. 纳入成本效益、可负担性及资源影响方面的考量
Health Res Policy Syst. 2006 Dec 5;4:23. doi: 10.1186/1478-4505-4-23.